×

收藏-健康网会员访问记录

网页标题:
×

注册健康网用户

用 户 名:
联 系 人:
性  别:
密  码:
重复密码:
电子邮箱:
邮箱验证码:
固定电话:
传  真:
手  机:
单位名称:
通信地址:
首选栏目:
×

找回密码

  • 1.选择找回方式
  • 2.确认验证信息
  • 3.修改密码
  • 4.修改成功
  • 找回方式:
  • 用 户 名:
  • 手机号码:

 您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Chinese Heparin derivatives market report

作者:wangchun   来源:本站原创    点击数:0    更新时间:2007-10-11 16:29:47

[关键字]: Heparin derivatives,report

健康网讯:

Research report of Chinese Heparin derivatives market(2007 version)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July, 2007
Format:  Hardcopy and Adobe PDF
Price:  US$1,500
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: [email protected]   [email protected]  


Brief introduction:
   Drugs of Heparin derivatives are import anticoagulants (direct anticoagulant), of which low molecular weight heparin sodium and low molecular weight heparin calcium are the mainstream products. In global market key brands include: Pfizer's "Fragmin", Sanofi-Avetnis's "Clexane" and "Fraxiparine" etc.
   The report presents the market size and development trend of Heparin derivatives, the sales values of different products, competitive manufacturers in China. The report also provides market forecasts and competitive and opportunity analysis in China.


The table of contents
1、Summary
2、Overview of blood thinning drugs
  2.1 Anticoagulant Drugs
  2.2 Antiplatelet drugs
  2.3 Others of Anticoagulant or Antiplatelet drugs
  2.4 Thrombolysis drugs
3 Sales analysis of blood thinning drugs from 2002 to 2006
  3.1 Market scale and growth trend
  3.2 Market share and change trend of different breeds
    3.2.1 Sales shares of different products of Blood Thinning Drugs
    3.2.2 Sales shares of different products of Antiplatelet drugs
    3.2.3  Sales shares of different products of Anticoagulant (Heparin) Drugs
    3.2.4 Sales shares of different products of Thrombolysis drugs
  3.3 Change about sales rank of key brands
4 Market analysis of Heparin derivatives in 2006
  4.1 Sales situation Heparin derivatives and other blood thinning
drugs in 2006
  4.2 Market shares of different categories of blood thinning drugs
in 2006
  4.3 Analysis about key manufacturers of blood thinning drugs
     Low molecular weight heparin sodium
     Low molecular weight heparin calcium
     Heparin sodium
     Heparin calium
     Sodium Citrate
5 Sales analysis of Heparin derivatives
6 Situation on global new drug research of blood thinning drugs
  6.1 Antiplatelet drugs
  6.2 Anticoagulant Drugs
7 Research and development in China
  7.1 List of Domestic marketd products and import procucts
  7.2 Status of application and approval for Blood Thinning Drugs

Appendix:
Appendix 1: Retail price of key blood thinning drugs
Appendix 2: The Anticoagulant Drugs and Thrombolysis drugs listed in Drug Catalogue of National Basic Medical Insurance
Appendix 3: The list of marketed Blood Thinning Drugs and the drugs during the period of application and approval

Chinese Heparin derivatives market report
注册后,我们会为你提供报告样本并为您提供更全面的咨询服务
您的姓名  称谓: 先生女士
手机号码 
验证号码 
电子邮件 
单位名称